Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization

Peritoneal fibrosis contributes to ultrafiltration failure in peritoneal dialysis (PD) patients and thus restricts the wide application of PD in clinic. Recently we have demonstrated that histone deacetylase 6 (HDAC6) is critically implicated in high glucose peritoneal dialysis fluid (HG-PDF) induce...

Full description

Bibliographic Details
Main Authors: Yingfeng Shi, Jinqing Li, Hui Chen, Yan Hu, Lunxian Tang, Xun Zhou, Min Tao, Zexin Lv, Si Chen, Andong Qiu, Na Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.899140/full
_version_ 1811243375353921536
author Yingfeng Shi
Jinqing Li
Hui Chen
Yan Hu
Lunxian Tang
Xun Zhou
Min Tao
Zexin Lv
Si Chen
Andong Qiu
Na Liu
author_facet Yingfeng Shi
Jinqing Li
Hui Chen
Yan Hu
Lunxian Tang
Xun Zhou
Min Tao
Zexin Lv
Si Chen
Andong Qiu
Na Liu
author_sort Yingfeng Shi
collection DOAJ
description Peritoneal fibrosis contributes to ultrafiltration failure in peritoneal dialysis (PD) patients and thus restricts the wide application of PD in clinic. Recently we have demonstrated that histone deacetylase 6 (HDAC6) is critically implicated in high glucose peritoneal dialysis fluid (HG-PDF) induced peritoneal fibrosis, however, the precise mechanisms of HDAC6 in peritoneal fibrosis have not been elucidated. Here, we focused on the role and mechanisms of HDAC6 in chlorhexidine gluconate (CG) induced peritoneal fibrosis and discussed the mechanisms involved. We found Tubastatin A (TA), a selective inhibitor of HDAC6, significantly prevented the progression of peritoneal fibrosis, as characterized by reduction of epithelial-mesenchymal transition (EMT) and extracellular matrix (ECM) protein deposition. Inhibition of HDAC6 remarkably suppressed the expression of matrix metalloproteinases-2 (MMP2) and MMP-9. Administration of TA also increased the expression of acetylation Histone H3 and acetylation α-tubulin. Moreover, our results revealed that blockade of HDAC6 inhibited alternatively M2 macrophages polarization by suppressing the activation of TGF-β/Smad3, PI3K/AKT, and STAT3, STAT6 pathways. To give a better understanding of the mechanisms, we further established two cell injured models in Raw264.7 cells by using IL-4 and HG-PDF. Our in vitro experiments illustrated that both IL-4 and HG-PDF could induce M2 macrophage polarization, as demonstrated by upregulation of CD163 and Arginase-1. Inhibition of HDAC6 by TA significantly abrogated M2 macrophage polarization dose-dependently by suppressing TGF-β/Smad, IL4/STAT6, and PI3K/AKT signaling pathways. Collectively, our study revealed that blockade of HDAC6 by TA could suppress the progression of CG-induced peritoneal fibrosis by blockade of M2 macrophage polarization. Thus, HDAC6 may be a promising target in peritoneal fibrosis treatment.
first_indexed 2024-04-12T14:06:20Z
format Article
id doaj.art-5470ce2ce4914dcd9df836068fc8b4f0
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T14:06:20Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-5470ce2ce4914dcd9df836068fc8b4f02022-12-22T03:30:03ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-06-011310.3389/fimmu.2022.899140899140Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage PolarizationYingfeng Shi0Jinqing Li1Hui Chen2Yan Hu3Lunxian Tang4Xun Zhou5Min Tao6Zexin Lv7Si Chen8Andong Qiu9Na Liu10Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaEmergency Department of Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaSchool of Life Science and Technology, Advanced Institute of Translational Medicine, Tongji University, Shanghai, ChinaDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaPeritoneal fibrosis contributes to ultrafiltration failure in peritoneal dialysis (PD) patients and thus restricts the wide application of PD in clinic. Recently we have demonstrated that histone deacetylase 6 (HDAC6) is critically implicated in high glucose peritoneal dialysis fluid (HG-PDF) induced peritoneal fibrosis, however, the precise mechanisms of HDAC6 in peritoneal fibrosis have not been elucidated. Here, we focused on the role and mechanisms of HDAC6 in chlorhexidine gluconate (CG) induced peritoneal fibrosis and discussed the mechanisms involved. We found Tubastatin A (TA), a selective inhibitor of HDAC6, significantly prevented the progression of peritoneal fibrosis, as characterized by reduction of epithelial-mesenchymal transition (EMT) and extracellular matrix (ECM) protein deposition. Inhibition of HDAC6 remarkably suppressed the expression of matrix metalloproteinases-2 (MMP2) and MMP-9. Administration of TA also increased the expression of acetylation Histone H3 and acetylation α-tubulin. Moreover, our results revealed that blockade of HDAC6 inhibited alternatively M2 macrophages polarization by suppressing the activation of TGF-β/Smad3, PI3K/AKT, and STAT3, STAT6 pathways. To give a better understanding of the mechanisms, we further established two cell injured models in Raw264.7 cells by using IL-4 and HG-PDF. Our in vitro experiments illustrated that both IL-4 and HG-PDF could induce M2 macrophage polarization, as demonstrated by upregulation of CD163 and Arginase-1. Inhibition of HDAC6 by TA significantly abrogated M2 macrophage polarization dose-dependently by suppressing TGF-β/Smad, IL4/STAT6, and PI3K/AKT signaling pathways. Collectively, our study revealed that blockade of HDAC6 by TA could suppress the progression of CG-induced peritoneal fibrosis by blockade of M2 macrophage polarization. Thus, HDAC6 may be a promising target in peritoneal fibrosis treatment.https://www.frontiersin.org/articles/10.3389/fimmu.2022.899140/fullperitoneal dialysisperitoneal fibrosishistone deacetylase 6macrophage polarizationtubastatin A
spellingShingle Yingfeng Shi
Jinqing Li
Hui Chen
Yan Hu
Lunxian Tang
Xun Zhou
Min Tao
Zexin Lv
Si Chen
Andong Qiu
Na Liu
Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization
Frontiers in Immunology
peritoneal dialysis
peritoneal fibrosis
histone deacetylase 6
macrophage polarization
tubastatin A
title Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization
title_full Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization
title_fullStr Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization
title_full_unstemmed Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization
title_short Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization
title_sort pharmacologic inhibition of histone deacetylase 6 prevents the progression of chlorhexidine gluconate induced peritoneal fibrosis by blockade of m2 macrophage polarization
topic peritoneal dialysis
peritoneal fibrosis
histone deacetylase 6
macrophage polarization
tubastatin A
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.899140/full
work_keys_str_mv AT yingfengshi pharmacologicinhibitionofhistonedeacetylase6preventstheprogressionofchlorhexidinegluconateinducedperitonealfibrosisbyblockadeofm2macrophagepolarization
AT jinqingli pharmacologicinhibitionofhistonedeacetylase6preventstheprogressionofchlorhexidinegluconateinducedperitonealfibrosisbyblockadeofm2macrophagepolarization
AT huichen pharmacologicinhibitionofhistonedeacetylase6preventstheprogressionofchlorhexidinegluconateinducedperitonealfibrosisbyblockadeofm2macrophagepolarization
AT yanhu pharmacologicinhibitionofhistonedeacetylase6preventstheprogressionofchlorhexidinegluconateinducedperitonealfibrosisbyblockadeofm2macrophagepolarization
AT lunxiantang pharmacologicinhibitionofhistonedeacetylase6preventstheprogressionofchlorhexidinegluconateinducedperitonealfibrosisbyblockadeofm2macrophagepolarization
AT xunzhou pharmacologicinhibitionofhistonedeacetylase6preventstheprogressionofchlorhexidinegluconateinducedperitonealfibrosisbyblockadeofm2macrophagepolarization
AT mintao pharmacologicinhibitionofhistonedeacetylase6preventstheprogressionofchlorhexidinegluconateinducedperitonealfibrosisbyblockadeofm2macrophagepolarization
AT zexinlv pharmacologicinhibitionofhistonedeacetylase6preventstheprogressionofchlorhexidinegluconateinducedperitonealfibrosisbyblockadeofm2macrophagepolarization
AT sichen pharmacologicinhibitionofhistonedeacetylase6preventstheprogressionofchlorhexidinegluconateinducedperitonealfibrosisbyblockadeofm2macrophagepolarization
AT andongqiu pharmacologicinhibitionofhistonedeacetylase6preventstheprogressionofchlorhexidinegluconateinducedperitonealfibrosisbyblockadeofm2macrophagepolarization
AT naliu pharmacologicinhibitionofhistonedeacetylase6preventstheprogressionofchlorhexidinegluconateinducedperitonealfibrosisbyblockadeofm2macrophagepolarization